Aesica appoints new Managing Director for API business unit

NEWCASTLE, UK: Aesica has appointed Kevin Cook as new Managing Director of its active pharmaceutical ingredient (API) business unit. Kevin will lead the business development team to promote the company’s API service offering and capabilities. His key area of focus will be to significantly grow the API business unit through the introduction of new product lines utilising existing assets and expansion through acquisition into India, Asia and further expansion across the US.

With over 25 years experience in the pharmaceutical manufacturing industry Kevin has worked with many companies growing and expanding their business base and supporting a number of successful mergers and acquisitions. Prior to joining Aesica, Kevin worked for Rhodia Pharma Solutions as Industrial Director and Shasun Pharma Solutions as President.

“It’s Aesica’s vision to become the leading global supplier of APIs and formulated products. I am looking forward to driving the API business unit forward while integrating with the formulated products and R5 formulation development units to promote Aesica’s service proposition and demonstrate our manufacturing capability,” said Kevin.

(C) WOC News